(MACK) Merrimack Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Merrimack Pharmaceuticals | (MACK) share price targets
Complete technical analysis of Merrimack Pharmaceuticals (MACK) by charts plus indicators, forecast predictions and share price targets for Merrimack Pharmaceuticals (MACK)
Merrimack Pharmaceuticals trades in USA in Health Care sector.
Showing technical analysis as on 2024-03-08 View latest technical analysis
10 day averaged volume of Merrimack Pharmaceuticals is 66500
Date | Daily Closing Price | Open | High | Low | Volume |
08 Fri Mar 2024 | 14.72 | 14.78 | 14.83 | 14.70 | 1.46 times |
07 Thu Mar 2024 | 14.77 | 14.71 | 14.78 | 14.70 | 1.173 times |
06 Wed Mar 2024 | 14.71 | 14.69 | 14.73 | 14.68 | 0.89 times |
05 Tue Mar 2024 | 14.69 | 14.74 | 14.75 | 14.68 | 1.147 times |
04 Mon Mar 2024 | 14.69 | 14.71 | 14.77 | 14.69 | 1.365 times |
01 Fri Mar 2024 | 14.74 | 14.68 | 14.78 | 14.68 | 1.32 times |
29 Thu Feb 2024 | 14.70 | 14.78 | 14.78 | 14.69 | 0.777 times |
28 Wed Feb 2024 | 14.70 | 14.69 | 14.76 | 14.68 | 0.605 times |
27 Tue Feb 2024 | 14.71 | 14.69 | 14.79 | 14.68 | 0.678 times |
26 Mon Feb 2024 | 14.70 | 14.67 | 14.80 | 14.67 | 1.047 times |
My analysis of stock is bullish for shortterm, and stock might move up till 14.9 or till 15.2. Use a stoploss of 14.64 and if this stock hits its stoploss, then it can fall down till 14.38
Share price targets for Merrimack Pharmaceuticals (MACK)
Target Type | Value |
Downside Target | 12.00 |
Downside Target | 12.56 |
Downside Target | 12.94 |
Downside Target | 13.52 |
Downside Target | 13.85 |
Downside Target | 14.61 |
Downside Target | 14.68 |
Upside Target | 14.80 |
Upside Target | 14.83 |
Upside Target | 15.89 |
Intraday share price targets for Merrimack Pharmaceuticals (MACK)
Target Type | Value |
Downside Intraday Target | 14.66 |
Downside Intraday Target | 14.59 |
Upside Intraday Target | 14.81 |
Upside Intraday Target | 14.89 |
Upside Intraday Target | 14.74 |
Weekly technical analysis of Merrimack Pharmaceuticals (MACK)
Date | Weekly Closing Price | Open | High | Low | Volume |
08 Fri Mar 2024 | 14.72 | 14.71 | 14.83 | 14.68 | 1.363 times |
01 Fri Mar 2024 | 14.74 | 14.67 | 14.80 | 14.67 | 0.663 times |
23 Fri Feb 2024 | 14.73 | 14.70 | 14.80 | 14.61 | 0.173 times |
16 Fri Feb 2024 | 14.70 | 13.75 | 15.89 | 13.55 | 5.644 times |
09 Fri Feb 2024 | 13.80 | 13.14 | 13.85 | 12.94 | 2.519 times |
Price has moved down this week, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming weeks.
Monthly technical analysis of Merrimack Pharmaceuticals (MACK)
Date | Monthly Closing Price | Open | High | Low | Volume |
08 Fri Mar 2024 | 14.72 | 14.68 | 14.83 | 14.68 | 0.13 times |
29 Thu Feb 2024 | 14.70 | 13.50 | 15.89 | 12.94 | 4.796 times |
31 Wed Jan 2024 | 13.40 | 13.40 | 13.56 | 12.96 | 0.751 times |
29 Fri Dec 2023 | 13.41 | 12.56 | 13.52 | 12.56 | 1.244 times |
Scroll below to view daily charts
Price has moved up this month, but volume has not increased substantially. This means that the move can be temporary and might not continue in coming months.
Indicators analysis of Merrimack Pharmaceuticals (MACK)
Price action analysis of Merrimack Pharmaceuticals ( (MACK) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Merrimack Pharmaceuticals ( (MACK) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Merrimack Pharmaceuticals ( (MACK) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Merrimack Pharmaceuticals ( (MACK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Merrimack Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Merrimack Pharmaceuticals in short term but the sell signal is initial and weak.
Merrimack Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Merrimack Pharmaceuticals in short term
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Merrimack Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.71 and Merrimack Pharmaceuticals (MACK) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Merrimack Pharmaceuticals (MACK) stock. Volume based technical analysis of Merrimack Pharmaceuticals (MACK) stock is negative.
Merrimack Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Merrimack Pharmaceuticals ( (MACK) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Merrimack Pharmaceuticals ( (MACK) ) based on a short term time period is positive, but buyers have become active on the stock recently. This cannot be a definite uptrend, specially if selected time duration is small.
Price action analysis of Merrimack Pharmaceuticals ( (MACK) ) based on a short to mid term time period is neutral. A longer time frame might give a better analysis.
Price action analysis of Merrimack Pharmaceuticals ( (MACK) ) based on a mid to longer term time period is definitely positive! This means that there is a strong uptrend in the stock for the given time period. Buyers are extremely bullish on the stock.
ADX buy sell signal for Merrimack Pharmaceuticals stock for short term is BUY. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Merrimack Pharmaceuticals in short term but the sell signal is initial and weak.
Merrimack Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are above the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Merrimack Pharmaceuticals in short term
RSI is generating a BUY signal in short term and the buying is gaining momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Merrimack Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 14.71 and Merrimack Pharmaceuticals (MACK) stock is trading above this level. This is a good sign for the stock and it could move higher. VWAP is falling down
People seem to be coming out and selling the Merrimack Pharmaceuticals (MACK) stock. Volume based technical analysis of Merrimack Pharmaceuticals (MACK) stock is negative.
Merrimack Pharmaceuticals Stock has given negative returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.